Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
Apply
T-DXd & Bevacizumab
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step